Abstract
Clinical interest and usefulness of the various marker determinations in staging, detection, prognosis, and monitoring of therapy in patients with tumors of different organ systems is discussed. It is stated that there is an urgent need for markers that can be used in early stage cancers, since neither the classical nor the new markers are sensitive or specific enough to be used for screening purposes or the detection of incipient malignancies. Despite having experienced frustrating limitations with the circulating markers these substances became of great interest as target antigens in histopathology and immunescintigraphy. These new applications of the tumor markers are also reviewed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
